NCT07088042View on ClinicalTrials.gov

Assessment of Different Medications in Modifying the Efficacy of Anesthesia in Mandibular Molars With Acute Irreversible Pulpitis

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 15, 2024

Primary Completion Date

February 17, 2025

Study Completion Date

February 17, 2025

Conditions

Pulpitis - Irreversible

Interventions

DRUG

Limitless Allzyme

Received Limitless Allzyme Max® Trypsin/Chymotrypsin/Bromelain(15 microkatal/42microkatal/240 GDU)

DRUG

Oral tablets of Alphintern®

received (Trypsin/Chymotrypsin 5 micro Katals/14 micro Katals)

DRUG

Cataflam® 50 coated tablet

of Cataflam 50 mg as part of their treatment protocol

Trial Locations (1)

4470351

Ain Shams University, Cairo

All Listed Sponsors

lead

Ain Shams University

OTHER

NCT07088042 - Assessment of Different Medications in Modifying the Efficacy of Anesthesia in Mandibular Molars With Acute Irreversible Pulpitis | Biotech Hunter | Biotech Hunter